These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4084356)

  • 1. Effect of plasma exchange with and without concomitant drug treatment on lipids and lipoproteins in patients with familial hypercholesterolemia confirmed by tissue culture.
    Keller C; Hailer S; Demant T; Wolfram G; Zöllner N
    Atherosclerosis; 1985 Nov; 57(2-3):225-34. PubMed ID: 4084356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of lovastatin alone and in combination with cholestyramine on serum lipids and apolipoproteins in heterozygotes for familial hypercholesterolemia.
    Leren TP; Hjermann I; Berg K; Leren P; Foss OP; Viksmoen L
    Atherosclerosis; 1988 Oct; 73(2-3):135-41. PubMed ID: 3056429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of beta-pyridylcarbinol on lipids and lipoprotein in primary type IIa hyperlipoproteinemia].
    Hutt V; Wechsler JG; Klör HU; Ditschuneit H
    Arzneimittelforschung; 1983; 33(12):1682-4. PubMed ID: 6686774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined drug therapy for familial hypercholesterolemia.
    Packard CJ; Stewart JM; Morgan HG; Lorimer AR; Shepherd J
    Artery; 1980; 7(4):281-9. PubMed ID: 7213018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma exchange in a patient with heterozygous familial hypercholesterolaemia resistant to drug therapy.
    Eriksson M; Lantz B; Berglund L; Angelin B
    Acta Med Scand; 1987; 221(3):317-20. PubMed ID: 3591471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipids and lipoproteins in hyperlipidemia type IIa during treatment with different lipid lowering drugs.
    Wechsler JG; Hutt V; Klör HU; Ditschuneit H
    Artery; 1980; 8(6):519-29. PubMed ID: 7259531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipids and lipoprotein changes after heart and liver transplantation in a patient with homozygous familial hypercholesterolemia.
    Valdivielso P; Escolar JL; Cuervas-Mons V; Pulpón LA; Chaparro MA; González-Santos P
    Ann Intern Med; 1988 Feb; 108(2):204-6. PubMed ID: 3277507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of atorvastatin on serum lipids and lipoproteins in patients with homozyous familial hypercholesterolemia undergoing LDL-apheresis therapy.
    Yamamoto A; Harada-Shiba M; Kawaguchi A; Oi K; Kubo H; Sakai S; Mikami Y; Imai T; Ito T; Kato H; Endo M; Sato I; Suzuki Y; Hori H
    Atherosclerosis; 2000 Nov; 153(1):89-98. PubMed ID: 11058703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Changes in serum lipids and lipoproteins in 3 cases of heterozygous familial hypercholesterolemia treated by LDL apheresis on dextran sulfate-cellulose columns].
    Delplanque B; Emmerich J; Norol F; Jourdan D; Duedari N; Jacotot B
    Ann Med Interne (Paris); 1988; 139 Suppl 1():80-2. PubMed ID: 2470282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial defective apolipoprotein B-100: a lesson from homozygous and heterozygous patients.
    Ceska R; Vrablík M; Horínek A
    Physiol Res; 2000; 49 Suppl 1():S125-30. PubMed ID: 10984082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma exchange treatment for severe familial hypercholesterolemia: a comparison of two different techniques.
    Dairou F; Rottembourg J; Truffert J; Assogba U; Bruckert E; de Gennes JL; Jacobs C
    Beitr Infusionsther; 1988; 23():152-9. PubMed ID: 2484771
    [No Abstract]   [Full Text] [Related]  

  • 12. Extracorporeal treatment of familial hypercholesterolemia with monoclonal antibodies to low-density lipoprotein.
    Wingard RL; Lee WO; Hakim RM
    Am J Kidney Dis; 1991 Nov; 18(5):559-65. PubMed ID: 1951335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonprogression of coronary artery atherosclerosis in homozygous familial hypercholesterolemia after 31 months of repetitive plasma exchange.
    Stein EA; Adolph R; Rice V; Glueck CJ; Spitz HB
    Clin Cardiol; 1986 Mar; 9(3):115-9. PubMed ID: 3948445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined treatment with cholestyramine and nicotinic acid in heterozygous familial hypercholesterolaemia: effects on biliary lipid composition.
    Angelin B; Eriksson M; Einarsson K
    Eur J Clin Invest; 1986 Oct; 16(5):391-6. PubMed ID: 3100307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of lovastatin on concentrations and composition of lipoprotein subfractions.
    Nozaki S; Vega GL; Haddox RJ; Dolan ET; Grundy SM
    Atherosclerosis; 1990 Oct; 84(2-3):101-10. PubMed ID: 2282090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein Lp(a) in homozygous familial hypercholesterolemia: density profile, particle heterogeneity and apolipoprotein(a) phenotype.
    Guo HC; Chapman MJ; Bruckert E; Farriaux JP; De Gennes JL
    Atherosclerosis; 1991 Jan; 86(1):69-83. PubMed ID: 1829609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined drug therapy--cholestyramine and compactin--for familial hypercholesterolemia.
    Yamamoto A; Yamamura T; Yokoyama S; Sudo H; Matsuzawa Y
    Int J Clin Pharmacol Ther Toxicol; 1984 Sep; 22(9):493-7. PubMed ID: 6500769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical efficacy and safety of cerivastatin in the treatment of heterozygous familial hypercholesterolemia.
    Mabuchi H; Koizumi J; Kajinami K
    Am J Cardiol; 1998 Aug; 82(4B):52J-55J. PubMed ID: 9737647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of combined fenofibrate and cholestyramine therapy on low-density lipoprotein kinetics in familial hypercholesterolemia patients.
    Malmendier CL; Delcroix C; Lontie JF
    Clin Chim Acta; 1987 Jan; 162(2):221-7. PubMed ID: 3829426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of beta-pyridylcarbinol on lipoprotein lipids in primary type IIa hyperlipoproteinemia.
    Schwandt P; Weisweiler P; Neureuther G
    Atherosclerosis; 1979 Sep; 34(1):35-9. PubMed ID: 227427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.